SKI Market

A+| A| A-|

Indian Indices

Sensex

75,867.80 -141.90
( -0.19%)

Global Indices

Nasdaq

50,493.86 -106.84
(-0.21%)

Dow Jones

7,540.47 46.00
(0.61%)

Hang Seng

65,194.32 198.23
(0.30%)

Nikkei 225

10,507.74 16.35
(0.16%)

Forex

USD-INR

95.26 -0.35
(-0.37%)

EUR-INR

110.89 -0.08
(-0.07%)

GBP-INR

128.53 0.11
(0.08%)

JPY-INR

0.60 0.00
(-0.21%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Jubilant Pharmova Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs

BSE Code

ISIN Demat

Book Value()

530019

INE700A01033

145.1556811

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

JUBLPHARMA

15695.03

EPS(TTM)

Face Value()

Div & Yield %

1.97

0.51

Back

Vedavaag Systems standalone net profit declines 49.25% in the December 2025 quarter

Feb 14,2026

Net profit of Vedavaag Systems declined 49.25% to Rs 1.02 crore in the quarter ended December 2025 as against Rs 2.01 crore during the previous quarter ended December 2024. Sales declined 9.37% to Rs 17.42 crore in the quarter ended December 2025 as against Rs 19.22 crore during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	17.42	19.22	-9
OPM %	11.77	17.79	-
PBDT	1.85	3.24	-43
PBT	1.23	2.74	-55
NP	1.02	2.01	-49

75,867.80 -141.90 ( -0.19%)

50,493.86 -106.84 (-0.21%)

7,540.47 46.00 (0.61%)

65,194.32 198.23 (0.30%)

10,507.74 16.35 (0.16%)

95.26 -0.35 (-0.37%)

110.89 -0.08 (-0.07%)

128.53 0.11 (0.08%)

0.60 0.00 (-0.21%)